Key result
Leadless pacemakers linked to ~85% fewer acute complications vs conventional CIEDs in high-risk patients.
Why the study?
Leadless intracardiac pacemakers were developed to reduce pocket- and lead-related complications associated with conventional CIEDs, such as infections, lead dislodgement, fracture, and septicemia.
Does leadless pacemaker implantation reduce complications compared to conventional CIEDs in a high-risk real-world population?
Observational (n=63)
No
Does leadless pacemaker implantation reduce complications compared to conventional CIEDs in a high-risk real-world population?
Leadless pacemakers offer a safe alternative to conventional CIEDs with a markedly lower rate of complications and infections in elderly, high-risk patients.
Answers are grounded in this paper and cite their sources.
May support leadless pacemaker use in high-risk elderly; hypothesis-generating and should not yet change practice.
Background Leadless intracardiac pacemakers have been developed to reduce complications associated with conventional cardiac implantable electronic devices (CIEDs), particularly pocket– and lead–related complications, including infections, lead dislodgement, fracture, and system–related septicemia Methods From September 2022 to December 2025, 63 leadless pacemakers were implanted in our center: 30 single–chamber devices, 32 VDD dual–chamber devices, and one dual–chamber system. Patients were predominantly male (49/63), with a mean age of 80.5 years and a mean follow–up of 528 days. Comorbidities included diabetes (25%), hypertension (73%), anticoagulant therapy (59%), and renal insufficiency (41%), including 8 patients with severe renal failure (predialysis or dialysis). Seventeen patients had a history of congestive heart failure; mean left ventricular ejection fraction at implantation was 55.4%. High–risk clinical features included prior CIED infection (n=3), limited vascular access (n=18), valvular prostheses (n=6), immunosuppression (n=25), recurrent sepsis (n=23), and active competitive endurance sports (n=2) Results Between 2024 and 2025, 668 conventional CIED procedures were performed at our center, with an overall acute complication rate of 10.8%, including pneumothorax (5.1%), pocket hematoma (5.7%), late lead dislodgement (5.4%), pocket revision for skin erosion (1.2%), and device–related infection (1.8%), with systemic involvement in three cases. Among the 63 leadless pacemaker implantations, only one mild vascular complication occurred (arteriovenous fistula with inguinal hematoma), successfully treated surgically without impact on survival. No acute pericardial effusion, device dislodgement, or loss of capture was observed during follow–up. No hospitalizations for device–related sepsis were reported Conclusions In a real–world population characterized by advanced age and high clinical risk, leadless pacemakers demonstrated an excellent safety profile, with a markedly lower rate of complications and infections compared with conventional CIED implantation. The absence of transvenous leads eliminates lead–related complications, while standardized implantation techniques enhance procedural safety. Despite higher upfront costs, leadless pacing represents a valuable option in selected patients at high septic risk or with limited vascular access, where reduced hospitalizations and avoidance of prolonged antibiotic therapy may offset initial expenses
No takes yet. Share an insight, caveat, or question.
Bricco et al. (2026) conducted an observational in Pacemaker indication with high clinical risk (n=63). Leadless pacemakers vs. Conventional CIEDs was evaluated on Acute complication rate. Leadless pacemakers demonstrated a lower rate of acute complications compared with conventional CIED implantation in a high-risk, real-world population.
Synapse has enriched 10 related papers. Consider them for comparative context: